| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Amphastar Pharma (NASDAQ:AMPH) through any online brokerage.
Other companies in Amphastar Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Amphastar Pharma has a consensus price target of $28.13.
The stock price for Amphastar Pharma (NASDAQ: AMPH) is $25.91 last updated October 6, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Amphastar Pharma.
Amphastar Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Amphastar Pharma.
Amphastar Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
